Secondary cytoreduction versus chemotherapy alone in the treatment of patients with recurrent ovarian cancer: is a randomized trial worthwhile?

Curr Oncol Rep. 2013 Jun;15(3):191. doi: 10.1007/s11912-013-0302-z.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Neoplasm Recurrence, Local / surgery*
  • Ovarian Neoplasms / surgery*
  • Ovary*